allumbra

allumbra is a blood test that catches head and neck cancer recurrence in most patients for whom circulating DNA tests do not work.

Health and bio

allumbra has no funding amount on record yet; its latest known round is Pre Seed (Mar 2026). Recent Funding first saw it on October 2, 2026.

Founders and team

• MN
  Maria Navas-Moreno Founder

  source: crunchbase.com

Raise history

1. March 9, 2026
   Pre Seed · amount undisclosed
   Source: crunchbase.com

Related bio health companies

• SSharp$328K · Oct 1, 2026
• MM-BasedOct 1, 2026
• AAyna HealthOct 1, 2026
• VVytalYou$830K · Sep 30, 2026
• LLindera USSep 29, 2026
• OOrtet$500M · Sep 29, 2026
• AAptadir Therapeutics$45M · Sep 29, 2026
• GGoerSep 29, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/allumbra.